| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1339 | 2020 |
| SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... Nature 587 (7833), 270-274, 2020 | 1261 | 2020 |
| COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ... Nature biotechnology 38 (8), 970-979, 2020 | 1064 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 794 | 2021 |
| Swarm learning for decentralized and confidential clinical machine learning S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ... Nature 594 (7862), 265-270, 2021 | 666 | 2021 |
| Estimating infectiousness throughout SARS-CoV-2 infection course TC Jones, G Biele, B Mühlemann, T Veith, J Schneider, ... Science 373 (6551), eabi5273, 2021 | 524 | 2021 |
| Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection CB Messner, V Demichev, D Wendisch, L Michalick, M White, A Freiwald, ... Cell systems 11 (1), 11-24. e4, 2020 | 500 | 2020 |
| Detection of prokaryotic mRNA signifies microbial viability and promotes immunity LE Sander, MJ Davis, MV Boekschoten, D Amsen, CC Dascher, B Ryffel, ... Nature 474 (7351), 385-389, 2011 | 484 | 2011 |
| Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses D Druzd, O Matveeva, L Ince, U Harrison, W He, C Schmal, H Herzel, ... Immunity 46 (1), 120-132, 2017 | 437 | 2017 |
| mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant H Gruell, K Vanshylla, P Tober-Lau, D Hillus, P Schommers, C Lehmann, ... Nature medicine 28 (3), 477-480, 2022 | 423 | 2022 |
| Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans P Bacher, T Hohnstein, E Beerbaum, M Röcker, MG Blango, S Kaufmann, ... Cell 176 (6), 1340-1355. e15, 2019 | 408 | 2019 |
| Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function LE Sander, SD Sackett, U Dierssen, N Beraza, RP Linke, M Müller, ... Journal of Experimental Medicine 207 (7), 1453-1464, 2010 | 393 | 2010 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 371 | 2021 |
| Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study D Hillus, T Schwarz, P Tober-Lau, K Vanshylla, H Hastor, C Thibeault, ... The Lancet Respiratory Medicine 9 (11), 1255-1265, 2021 | 364 | 2021 |
| A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 344 | 2020 |
| Beyond pattern recognition: five immune checkpoints for scaling the microbial threat JM Blander, LE Sander Nature Reviews Immunology 12 (3), 215-225, 2012 | 341 | 2012 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 320 | 2020 |
| Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, ... Nature biotechnology 40 (3), 319-324, 2022 | 315 | 2022 |
| Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense J Garaude, R Acín-Pérez, S Martínez-Cano, M Enamorado, M Ugolini, ... Nature immunology 17 (9), 1037-1045, 2016 | 303 | 2016 |
| Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination L Loyal, J Braun, L Henze, B Kruse, M Dingeldey, U Reimer, F Kern, ... Science 374 (6564), eabh1823, 2021 | 265 | 2021 |
